Your Current Location : Fund Card : Fund Summary |
|
|
|
Nippon India Pharma Fund IDCW Direct |
|
[Equity: Sectoral] |
|
|
|
Fund Details |
Fund Type |
Dividend |
Launch Date |
14 Jan 2013 |
Corpus(Cr.) |
6891.0 |
Scheme NAV |
151.324 |
Equity(%) |
97.94 |
52 Week High |
163.772 |
Debt(%) |
2.06 |
52 Week Low |
100.463 |
Others(%) |
0.0 |
Exit Load |
1% for redemption Within 30 days |
Minimum Investment |
- |
Availability |
Open |
Entry Load |
- |
Expense Ratio(%) |
0.97 |
Scheme Benchmark |
S&P BSE Healthcare TRI |
Broader Benchmark |
NSE - Nifty 50 TRI |
|
|
Scheme Objective |
Investment Strategy The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies. |
|
Last 10 Dividends |
Date of Dividend Declaration |
Dividend (Individual) Per Unit(Rs.) |
Dividend (Corporate) Per Unit(Rs.) |
25-02-2022 |
3.50 |
3.50 |
26-02-2021 |
6.00 |
6.00 |
28-02-2020 |
3.98 |
3.98 |
01-03-2019 |
4.43 |
4.43 |
01-03-2018 |
6.00 |
6.00 |
|
|
|
|
|
|
|
|
|
|
|